EUVIMEDEUVIMED entdecken
Editorial

Finerenone: Do We Really Need an Additional Therapy in Type 2 Diabetes Mellitus and Kidney Disease?

Deepika Manoharan, Nicholas Gangoo, William Hinchliffe

British Journal of Hospital Medicine · 2025

DOI: 10.12968/hmed.2024.0715 ↗

Kurz gefasst

Editorial in der Zeitschrift British Journal of Hospital Medicine, 2025. Verfasst von Deepika Manoharan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Department, Sunderland Royal Hospital, Sunderland, UK. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Mineralocorticoid Receptor Antagonists, Renal Insufficiency, Chronic, Naphthyridines. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM) face considerable cardiorenal morbidity and mortality despite existing therapies. Recent clinical trials demonstrate the efficacy of finerenone, a novel non-steroidal mineralocorticoid receptor antagonist, in reducing adverse renal and cardiovascular outcomes. This editorial briefly reviews the evidence and its implications for clinical practice, advocating the use of finerenone in these high-risk patients in combination with currently established treatment agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Mineralocorticoid Receptor AntagonistsRenal Insufficiency, ChronicNaphthyridinesDiabetic NephropathiesHumansDrug Therapy, CombinationCardiovascular Diseases

Stichwörter der Autor:innen

chronic kidney diseasediabetic nephropathytype 2 diabetes

Substanzen

finerenoneMineralocorticoid Receptor AntagonistsNaphthyridines

Autor:innen und Institutionen

  • Nephrology Department, Sunderland Royal Hospital, Sunderland, UK.

Zitieren

APA

Manoharan, D., Gangoo, N., & Hinchliffe, W. (2025). Finerenone: Do We Really Need an Additional Therapy in Type 2 Diabetes Mellitus and Kidney Disease?. British Journal of Hospital Medicine. https://doi.org/10.12968/hmed.2024.0715

Vancouver

Manoharan D, Gangoo N, Hinchliffe W. Finerenone: Do We Really Need an Additional Therapy in Type 2 Diabetes Mellitus and Kidney Disease?. British Journal of Hospital Medicine. 2025. doi:10.12968/hmed.2024.0715

BibTeX
@article{Manoharan2025,
  author = {Manoharan, Deepika and Gangoo, Nicholas and Hinchliffe, William},
  title = {Finerenone: Do We Really Need an Additional Therapy in Type 2 Diabetes Mellitus and Kidney Disease?},
  journal = {British Journal of Hospital Medicine},
  year = {2025},
  doi = {10.12968/hmed.2024.0715}
}
Kostenlos starten →